Eric Dobmeier - 25 Jun 2024 Form 4 Insider Report for Structure Therapeutics Inc. (GPCR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jun 2024, 16:15:08 UTC
Prior SEC filing
14 Nov 2023
Next SEC filing
22 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jun Yoon, Attorney-in-Fact

Key filing fact

Eric Dobmeier filed Form 4 for Structure Therapeutics Inc. (GPCR) on 27 Jun 2024.

Key facts

  • This page summarizes Eric Dobmeier's Form 4 filing for Structure Therapeutics Inc. (GPCR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jun 2024, 16:15.

Change

  • Previous filing in this sequence was filed on 14 Nov 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GPCR transaction Derivative

Share Option (right to buy)

Award

Transaction value
$0
Shares
+37,500
Change %
Price
$0.000000
Shares after
37,500
Date
25 Jun 2024
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
37,500
Exercise price
$13.32
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").

Footnote F2

The shares vest in equal monthly installments over the 12 months following June 25, 2024.

Footnote F3

The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .